Board meeting on 31 Oct 2026 to consider Q2 FY27 results

Results View source PDF Explain this filing

CLEAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.4%Reaction day

₹783.75

prior close

₹784.00

announcement price

After-mkt

timing

Nifty Smallcap 250market-1.1%-2.3% vs market

Specialty Chemicals peers, median of 101sector-1.8%-1.7% vs sector

On the reaction day the stock moved 2.3 pts less than Nifty Smallcap 250 and 1.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

-0.2

15m

-0.3

30m

-1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.4-1.1-2.3-1.8-1.7

Next day

-5.8-3.4-2.5-4.8-1.0

-4.8-4.4-0.4-5.7+1.0

-8.5-7.1-1.4-9.0+0.4

-5.6-6.1+0.4-9.0+3.3

-6.1pendingpending-7.2+1.1

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 101Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The company has informed BSE that its Board of Directors will meet on Saturday, 31 October 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026. The trading window for designated persons and their immediate relatives is closed from 1 October 2026 until 48 hours after the results are announced. This is a routine prior intimation filed under SEBI listing regulations.

Likely market impact

Routine regulatory intimation with no immediate price impact. Investors should watch for the actual Q2 results on 31 October 2026.